Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Management of incidentally diagnosed pulmonary artery dissection in patients with pulmonary arterial hypertension.

Nuche J, Montero Cabezas JM, Alonso Charterina S, Escribano Subías P.

Eur J Cardiothorac Surg. 2018 Dec 7. doi: 10.1093/ejcts/ezy387. [Epub ahead of print]

PMID:
30534961
2.

Frequency, Predictors, and Prognostic Impact of Pulmonary Artery Aneurysms in Patients With Pulmonary Arterial Hypertension.

Nuche J, Montero Cabezas JM, Jiménez López-Guarch C, Velázquez Martín M, Alonso Charterina S, Revilla Ostolaza Y, Arribas Ynsaurriaga F, Escribano Subías P.

Am J Cardiol. 2019 Feb 1;123(3):474-481. doi: 10.1016/j.amjcard.2018.10.028. Epub 2018 Nov 6.

PMID:
30477804
3.

Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension.

Cunningham KP, Holden RG, Escribano-Subias PM, Cogolludo A, Veale EL, Mathie A.

J Physiol. 2019 Feb;597(4):1087-1101. doi: 10.1113/JP277275. Epub 2018 Nov 24.

PMID:
30365877
4.

Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry.

Del Pozo R, Blanco I, Hernández-González I, López-Meseguer M, López-Reyes R, Lázaro-Salvador M, Elías-Hernández T, Álvarez-Vega P, Pérez-Peñate GM, Martínez-Meñaca A, Bedate P, Escribano-Subias P; REHAP investigators.

Int J Cardiol. 2019 Jan 15;275:158-164. doi: 10.1016/j.ijcard.2018.10.012. Epub 2018 Oct 5.

PMID:
30316648
5.

Evaluation of a nurse-led intervention program in heart failure: A randomized trial.

Ortiz-Bautista C, Morán-Fernández L, Díaz-García M, Delgado-Nicolás MÁ, Ponz-de Antonio I, Rodríguez-Chaverri A, García-Cosio MD, de Juan-Bagudá J, Lora-Pablos D, Sánchez-Sánchez V, Escribano-Subías P, Bueno H, Arribas-Ynsaurriaga F, Delgado-Jiménez JF.

Med Clin (Barc). 2018 Oct 9. pii: S0025-7753(18)30514-1. doi: 10.1016/j.medcli.2018.08.005. [Epub ahead of print] English, Spanish.

PMID:
30314739
6.

Living With Severe Pulmonary Arterial Hypertension Without an Infusion Pump? Selexipag has a Role to Play.

Lázaro Salvador M, Akerström F, Escribano Subías P, Berenguel Senén A, Martinez Mateo V, Rodriguez Padial L.

Arch Bronconeumol. 2019 Feb;55(2):102-103. doi: 10.1016/j.arbres.2018.03.010. Epub 2018 Jul 27. English, Spanish. No abstract available.

7.

Physical activity levels are low in patients with pulmonary hypertension.

González-Saiz L, Santos-Lozano A, Fiuza-Luces C, Sanz-Ayán P, Quezada-Loaiza CA, Ruiz-Casado A, Alejo LB, Flox-Camacho A, Morán M, Lucia A, Escribano-Subías P.

Ann Transl Med. 2018 Jun;6(11):205. doi: 10.21037/atm.2018.05.37.

8.

Letter by Hernandez-Gonzalez et al Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".

Hernandez-Gonzalez I, Navas P, Escribano-Subias P.

Circulation. 2018 May 29;137(22):2411-2412. doi: 10.1161/CIRCULATIONAHA.118.033641. No abstract available.

PMID:
29844074
9.

Extracorporeal Membrane Oxygenation Support During Pregnancy in Pulmonary Veno-occlusive Disease.

Ortiz-Bautista C, López-Gude MJ, Grande García J, Pérez-Vela JL, Pérez-González V, Escribano-Subías P.

Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):174-175. doi: 10.1016/j.rec.2018.01.001. Epub 2018 Feb 7. English, Spanish. No abstract available.

PMID:
29428338
10.

Selection of the Best of 2017 in Pulmonary Hypertension.

Lázaro Salvador M, Escribano Subias P, Castro Fernández A, Hernández Simón P, Berenguel Senén A, Rodríguez Padial L.

Rev Esp Cardiol (Engl Ed). 2018 Apr;71(4):299-300. doi: 10.1016/j.rec.2017.10.043. Epub 2018 Jan 8. English, Spanish. No abstract available.

PMID:
29326064
11.

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.

Bermejo J, Yotti R, García-Orta R, Sánchez-Fernández PL, Castaño M, Segovia-Cubero J, Escribano-Subías P, San Román JA, Borrás X, Alonso-Gómez A, Botas J, Crespo-Leiro MG, Velasco S, Bayés-Genís A, López A, Muñoz-Aguilera R, de Teresa E, González-Juanatey JR, Evangelista A, Mombiela T, González-Mansilla A, Elízaga J, Martín-Moreiras J, González-Santos JM, Moreno-Escobar E, Fernández-Avilés F; Sildenafil for Improving Outcomes after VAlvular Correction (SIOVAC) investigators .

Eur Heart J. 2018 Apr 14;39(15):1255-1264. doi: 10.1093/eurheartj/ehx700.

12.

Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization.

Montero Cabezas JM, Nuche Berenguer J, Velázquez Martín MT, Escribano Subías P.

J Am Coll Cardiol. 2017 Nov 7;70(19):2459-2460. doi: 10.1016/j.jacc.2017.07.799. No abstract available.

13.

Variable Expressivity of a Founder Mutation in the EIF2AK4 Gene in Hereditary Pulmonary Veno-occlusive Disease and Its Impact on Survival.

Navas Tejedor P, Palomino Doza J, Tenorio Castaño JA, Enguita Valls AB, Rodríguez Reguero JJ, Martínez Meñaca A, Hernández González I, Bueno Zamora H, Lapunzina Badía PD, Escribano Subías P.

Rev Esp Cardiol (Engl Ed). 2018 Feb;71(2):86-94. doi: 10.1016/j.rec.2017.03.034. Epub 2017 Jul 9. English, Spanish.

PMID:
28697925
14.

Reply.

Ortiz-Bautista C, Hernández-González I, Escribano-Subías P.

Med Clin (Barc). 2017 Oct 11;149(7):320-321. doi: 10.1016/j.medcli.2017.05.028. Epub 2017 Jun 24. English, Spanish. No abstract available.

PMID:
28655438
15.

Trends in Pulmonary Hypertension Over a Period of 30 Years: Experience From a Single Referral Centre.

Quezada Loaiza CA, Velázquez Martín MT, Jiménez López-Guarch C, Ruiz Cano MJ, Navas Tejedor P, Carreira PE, Flox Camacho Á, de Pablo Gafas A, Delgado Jiménez JF, Gómez Sánchez MÁ, Escribano Subías P.

Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):915-923. doi: 10.1016/j.rec.2016.12.044. Epub 2017 Apr 26. English, Spanish.

PMID:
28454887
16.

The prostacyclin pathway in pulmonary arterial hypertension: a clinical review.

Del Pozo R, Hernandez Gonzalez I, Escribano-Subias P.

Expert Rev Respir Med. 2017 Jun;11(6):491-503. doi: 10.1080/17476348.2017.1317599. Epub 2017 Apr 24. Review.

PMID:
28399721
17.

Effects of an 8-month exercise intervention on physical capacity, NT-proBNP, physical activity levels and quality of life data in patients with pulmonary arterial hypertension by NYHA class.

Santos-Lozano A, Sanz-Ayan P, González-Saiz L, Quezada-Loaiza CA, Fiuza-Luces C, Flox-Camacho A, Munguía-Izquierdo D, Santalla A, Morán M, Escribano-Subías P, Lucia A.

Data Brief. 2017 Mar 18;12:37-41. doi: 10.1016/j.dib.2017.03.022. eCollection 2017 Jun.

18.

Myocardial injury in severe heritable pulmonary veno-occlusive disease.

Ortiz-Bautista C, Bueno H, Escribano-Subías P.

J Heart Lung Transplant. 2017 Jul;36(7):818-820. doi: 10.1016/j.healun.2017.02.013. Epub 2017 Feb 17. No abstract available.

PMID:
28320632
19.

Pulmonary endarterectomy outputs in chronic thromboembolic pulmonary hypertension.

López Gude MJ, Pérez de la Sota E, Pérez Vela JL, Centeno Rodríguez J, Muñoz Guijosa C, Velázquez MT, Alonso Chaterina S, Hernández González I, Escribano Subías P, Cortina Romero JM.

Med Clin (Barc). 2017 Jul 7;149(1):1-8. doi: 10.1016/j.medcli.2016.12.032. Epub 2017 Feb 21. English, Spanish.

PMID:
28233561
20.

Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: The WHOLEi+12 trial.

González-Saiz L, Fiuza-Luces C, Sanchis-Gomar F, Santos-Lozano A, Quezada-Loaiza CA, Flox-Camacho A, Munguía-Izquierdo D, Ara I, Santalla A, Morán M, Sanz-Ayan P, Escribano-Subías P, Lucia A.

Int J Cardiol. 2017 Mar 15;231:277-283. doi: 10.1016/j.ijcard.2016.12.026.

PMID:
28189191

Supplemental Content

Loading ...
Support Center